会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • COMPOSITION CONTAINING 4-O-METHYLHONOKIOL FOR TREATING OR PREVENTING AMYLOID- RELATED DISEASES
    • 含有4-O-甲基羟基木酚醇的组合物用于治疗或预防淀粉样蛋白相关性疾病
    • WO2010036052A3
    • 2010-07-22
    • PCT/KR2009005485
    • 2009-09-25
    • BIOLAND LTDKIM KI HOKIM KI SOOKIM YOUNG HEUIKIM JIN GUKKIM KYOUNG TAEHAN CHANG SUNGLEE SANG IL
    • KIM KI HOKIM KI SOOKIM YOUNG HEUIKIM JIN GUKKIM KYOUNG TAEHAN CHANG SUNGLEE SANG IL
    • A61K31/085A23L1/29A23L1/30A61K31/05A61P25/28
    • A61K31/085A23L2/52A23L33/105A61K31/05A61K36/575
    • The present invention relates to a composition for treating or preventing amyloid-related diseases, said composition containing 4-O-methylhonokiol as an active ingredient. More particularly, the present invention relates to a pharmaceutical composition which contains as an active ingredient and which is useful in treating or preventing amyloid-related diseases such as Alzheimer's disease, cognitive disorders, memory impairment, amyloidosis, etc. The inventors of the present invention first found that 4-O-methylhonokiol of the present invention inhibits the formation of beta-amyloid, and it is evidenced that 4-O-methylhonokiol can be used in the treatment and prevention of amyloid-related diseases. The inventors of the present invention have performed animal tests such as a water maze test, a passive avoidance test, and the like using experimental rats to find that 4-O-methylhonokiol is effective in the treatment or prevention of amyloid-related diseases such as Alzheimer's disease, cognitive disorders, memory impairment, amyloidosis, etc. The inventors of the prevent invention further have performed an acetylcholinesterase activity inhibition test using the cortex and hippocampus of the brain of a rat to find that 4-O-methylhonokiol is significantly effective in the treatment or prevention of Alzheimer's disease specifically from among the amyloid-related diseases.
    • 本发明涉及用于治疗或预防淀粉样蛋白相关疾病的组合物,所述组合物含有4-O-甲基和厚朴酚作为活性成分。 更具体地说,本发明涉及含有作为活性成分并可用于治疗或预防淀粉样蛋白相关疾病如阿尔茨海默病,认知障碍,记忆障碍,淀粉样变性等的药物组合物。本发明的发明人 首先发现本发明的4-O-甲基和厚朴酚抑制β-淀粉样蛋白的形成,并且证明4-O-甲基和厚朴酚可用于治疗和预防淀粉样蛋白相关疾病。 本发明的发明人使用实验大鼠进行了水迷宫试验,被动回避试验等动物试验,结果发现4-O-甲基和厚朴酚有效治疗或预防淀粉样蛋白相关疾病,例如 阿尔茨海默病,认知障碍,记忆障碍,淀粉样变性等。本发明的发明人进一步使用大鼠脑的皮质和海马进行了乙酰胆碱酯酶活性抑制试验,发现4-O-甲基和厚朴酚在 特别是从淀粉样蛋白相关疾病中治疗或预防阿尔茨海默病。